Nov 9 (Reuters) - Oncopeptides AB ONCO.ST :
* ONCOPEPTIDES ANNOUNCES THE MARKET POTENTIAL FOR PEPAXTI IN
EUROPE
* POTENTIAL ASSUMES THAT TYPE 2 VARIATION SUBMISSION TO
EUROPEAN
MEDICINES AGENCY BASED ON OCEAN DATA, WILL BE APPROVED BY AGENCY
* MARKET POTENTIAL ASSUMES THAT PRICE NEGOTIATIONS WILL
REFLECT
DEGREE OF INNOVATION OF DRUG AND CLINICAL BENEFIT TO PATIENTS
Source text for Eikon: ID:nWkr8T1xVJ
Further company coverage: ONCO.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))